TABLE 3.
One-Dose and Two-Dose Varicella Vaccine Effectiveness Against All Varicella by Time Since Vaccination in Public School Students of West Virginia, 2010–2011
| Cases, n (%) | Controls, n (%) | VE (95% CI) | P Value | P Value | |
|---|---|---|---|---|---|
| Unvaccinated | 57 (50.4) | 36 (16.6) | Reference | ||
| Years since receipt of first dose of varicella vaccine | N = 56 | N = 181 | |||
| <5 years | 4 (3.5) | 31 (14.3) | 93.0 (75.0–98.1) | <0.001 | Reference |
| 5–9 years | 31 (27.4) | 93 (42.9) | 88.0 (72.4–94.8) | <0.001 | 0.36 |
| ≥10 years | 21 (18.6) | 57 (26.3) | 81.8 (57.8–92.1) | <0.001 | 0.15 |
| Years since receipt of second dose of varicella vaccine | N = 20 | N = 148 | |||
| <3 years | 7 (9.7) | 65 (90.3) | 92.8 (72.4–98.1) | <0.001 | Reference |
| 3–5 years | 11 (12.5) | 77 (87.5) | 87.8 (65.1–95.8) | <0.001 | 0.240 |
| >5 years | 2 (25.0) | 6 (75.0) | 50.7 (0–97.5) | 0.64 | <0.001 |
VE indicates vaccine effectiveness; 95% CI, 95% confidence interval.